CrushSCI.com
Journal Selection & Manuscript Polishing Services
CANCER journal cover Medicine
Back to journal directory

Review Cycle Records

CANCER

Wiley SCIE Non-OA
2026 Emerging Zone 22025 CAS Zone 1 TOP2025 JCR Q1
109.5Average days
97Median days
41Fastest days
237Longest days
5272025 publications

Paper Review Records

All Paper Review Records

20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

77 days

Clinical management of clonal hematopoiesis

AuthorsKelly S. Chien; Guillermo Garcia‐Manero

Affiliations1. Department of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas USA

Source PDF DOI Publisher page
51 days

A systematic review of international/national guidelines for the management of nasopharyngeal carcinoma: Convergence and divergence of recommendations

AuthorsQin Liu; Handoko; Ji‐Shi Li; Qiao‐Juan Guo; Fernando Lopez; Primož Strojan; James C. H. Chow; Orlando Guntinas‐Lichius; Karthik N. Rao; Sweet Ping Ng; Sandra Nuyts; Wai‐Tong Ng; Nabil F. Saba; Carlos Chiesa‐Estomba; M. P. Sreeram; Alfio Ferlito; Anne W. M. Lee

Affiliations1. Department of Radiation Oncology Fujian Medical University Union Hospital Fuzhou China; 2. Fujian Key Laboratory of Intelligent Imaging and Precision Radiotherapy for Tumors Fujian Medical University Fuzhou China; 3. Digestive, Hematological, and Breast Malignancies Clinical Research Center for Radiology and Radiotherapy of Fujian Province Fuzhou China; 4. Department of Clinical Oncology University of Hong Kong Hong Kong Special Administrative Region China; 5. Department of Radiation Oncology Cipto Mangunkusumo Hospital, Faculty of Medicine Universitas Indonesia Depok Indonesia; 6. Clinical Oncology Center University of Hong Kong–Shenzhen Hospital Shenzhen China; 7. Clinical Oncology School of Fujian Medical University Fujian Cancer Hospital Fujian Medical University Fuzhou Fujian China; 8. Department of Otolaryngology Hospital Universitario Central de Asturias University of Oviedo, Instituto de Investigación Sanitaria del Principado de Asturias, Instituto Universitario de Oncología del Principado de Asturias, Centro de Investigación en Red Cáncer Proyectos Oviedo Spain; 9. Department of Radiation Oncology Institute of Oncology Ljubljana Slovenia; 10. Department of Clinical Oncology Queen Elizabeth Hospital Hong Kong Special Administrative Region China; 11. Department of Otorhinolaryngology Jena University Hospital Jena Germany; 12. Department of Head and Neck Surgical Oncology Sri Shankara Cancer Hospital and Research Center Bangalore India; 13. Department of Radiation Oncology Austin Health, Melbourne Heidelberg Victoria Australia; 14. Laboratory of Experimental Radiotherapy Department of Oncology Katholieke Universiteit Leuven Leuven Belgium; 15. Department of Radiation Oncology Leuven Cancer Institute University Hospitals Leuven Leuven Belgium; 16. Department of Hematology and Medical Oncology The Winship Cancer Institute Emory University Atlanta Georgia USA; 17. Department of Otolaryngology–Head and Neck Surgery Donostia University Hospital San Sebastian Spain; 18. Faculty of Medicine Deusto University Bilbao Spain; 19. Department of Head and Neck Surgery Sri Shankara Cancer Hospital and Research Centre Bangalore India; 20. International Head and Neck Scientific Group Padua Italy

Source PDF DOI Publisher page
72 days

T‐cell engagers in small cell lung cancer

AuthorsAlissa J Cooper; Jacob Sands

Affiliations1. Dana‐Farber Cancer Institute Boston MA USA

Source PDF DOI Publisher page
113 days

Male survivors of childhood cancer and perceptions of sexual dysfunction risk: A report from the Childhood Cancer Survivor Study

AuthorsJenna Demedis; Kayla L. Stratton; Wendy M. Leisenring; Tara M. Brinkman; Rebecca M. Howell; Gregory T. Armstrong; Lillian R. Meacham; Eric J. Chow; Jordan Gilleland Marchak

Affiliations1. Department of Pediatrics University of Colorado School of Medicine Aurora Colorado USA; 2. Center for Cancer and Blood Disorders Children’s Hospital Colorado Aurora Colorado USA; 3. Fred Hutchinson Cancer Center Seattle Washington USA; 4. Department of Psychology and Biobehavioral Sciences St. Jude Children's Research Hospital Memphis Tennessee USA; 5. Department of Radiation Physics MD Anderson Cancer Center Houston Texas USA; 6. Department of Epidemiology and Cancer Control St. Jude Children's Research Hospital Memphis Tennessee USA; 7. Aflac Cancer and Blood Disorders Center Children's Healthcare of Atlanta Atlanta Georgia USA; 8. Clinical Research Division and Public Health Sciences Division Fred Hutchinson Cancer Center Seattle Washington USA; 9. Department of Pediatrics Emory University School of Medicine Atlanta Georgia USA

Source PDF DOI Publisher page
175 days

The evolving role of immunotherapy in ovarian cancer

AuthorsAna Carolina Veneziani; Laura Venegas; Amit M. Oza

Affiliations1. Division of Medical Oncology and Hematology Princess Margaret Cancer Centre University Health Network Toronto Ontario Canada; 2. Department of Medicine University of Toronto Toronto Ontario Canada

Source PDF DOI Publisher page
111 days

Prevalence of breast, cervical, and colorectal cancer screening among adults according to disability type and difficulty level, United States, 2021 and 2023

AuthorsNatalia Mazzitelli; Jessica Star; Kinsey Meggett; Xuesong Han; Priti Bandi

Affiliations1. Surveillance, Prevention, and Health Services Research American Cancer Society Atlanta Georgia USA; 2. Public Health Sciences Clemson University Clemson South Carolina USA

Source PDF DOI Publisher page
70 days

Elevated risk of ischemic stroke after invasive cancer diagnosis: A nationwide population‐based study

AuthorsCarmit Libruder; David Tanne; Barbara G. Silverman; Binyamin Binyaminy; Rita Dichtiar; Lital Keinan‐Boker

Affiliations1. School of Public Health University of Haifa Haifa Israel; 2. Israel Center for Disease Control Israel Ministry of Health Ramat Gan Israel; 3. Rambam Health Care Campus Haifa Israel; 4. Technion Faculty of Medicine Haifa Israel

Source PDF DOI Publisher page
117 days

Long‐term outcomes and patterns of failure in patients with thymic malignancies treated with surgery and radiation therapy

AuthorsOded Icht; Inbar Nardi‐Agmon; Paaladinesh Thavendiranathan; Shaf Keshavjee; Amiya Agrawal; John‐Michael Miro; Omar Badran; Geoffrey Liu; Xiang Y. Ye; B. C. John Cho; Andrea Bezjak; Andrew Hope

Affiliations1. Radiation Medicine Program Princess Margaret Cancer Centre University Health Network Toronto Ontario Canada; 2. Department of Radiation Oncology University of Toronto Toronto Ontario Canada; 3. Gray Faculty of Medical and Health Sciences Tel‐Aviv University Tel‐Aviv Israel; 4. Department of Medicine Division of Cardiology Ted Rogers Program in Cardiotoxicity Prevention Peter Munk Cardiac Center Toronto General Hospital University Health Network University of Toronto Toronto Ontario Canada; 5. Division of Thoracic Surgery University of Toronto Toronto General Hospital and Princess Margaret Cancer Centre University Health Network Toronto Ontario Canada; 6. Department of Medical Oncology Princess Margaret Cancer Centre Toronto Ontario Canada; 7. Department of Biostatistics Princess Margaret Cancer Centre University Health Network Toronto Ontario Canada

Source PDF DOI Publisher page
41 days

GPRC5D‐targeting bispecific and trispecific antibodies in multiple myeloma: Current evidence and emerging strategies

AuthorsDarren Pan; Anupama Kumar; Jodi J. Lipof; Alfred Chung; Jeffrey L. Wolf; Thomas G. Martin; Shagun Arora; Peter H. Sayre; Ajai Chari

Affiliations1. Department of Medicine University of California San Francisco California USA

Source PDF DOI Publisher page
79 days

Adjuvant CDK4/6 inhibitors in early‐stage breast cancer: Clinical evidence and considerations for risk stratification and treatment selection

AuthorsAustin D. Williams; Anna Weiss

Affiliations1. Division of Breast Surgery Department of Surgery Fox Chase Cancer Center Philadelphia Pennsylvania USA; 2. Pluta Cancer Center University of Rochester Rochester New York USA

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.